Context Therapeutics Inc.
USD0.58
+0.02 (+3.57%)
CEO
Martin A. Lehr
IPO Date
2021-10-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.56
Prev. Close
$0.56
Day Low
$0.56
Day High
$0.62
52W Low
$0.55
52W High
$3.62
Market Cap
$0.05B
Volume
14.82M
| 45,000 |
| $0.58 |
| 26 Jun 2026 | West Linda | director | A-Award | Acquired | 45,000 | $0.58 |
| 26 Jun 2026 | Smith Karen L. | director | A-Award | Acquired | 45,000 | $0.58 |
| 26 Jun 2026 | Walker Luke Nathaniel | director | A-Award | Acquired | 45,000 | $0.58 |
| 26 Jun 2026 | Kantoff Philip W. | director | A-Award | Acquired | 45,000 | $0.58 |
| 23 Feb 2026 | Levit Alex C. | Chief Legal Officer, Corp. Sec | A-Award | Acquired | 270,000 | $2.32 |
| 23 Feb 2026 | Minai-Azary Jennifer Lynn | Chief Financial Officer | A-Award | Acquired | 275,000 | $2.32 |
| 23 Feb 2026 | Chagin Karen Deborah | Chief Medical Officer | A-Award | Acquired | 290,000 | $2.32 |
| 23 Feb 2026 | Lehr Martin A. | director, officer: Chief Executive Officer | A-Award | Acquired | 815,000 | $2.32 |